Spirulina and EZH2/Polycomb

Polycomb Repressive Complex 2: The H3K27 Methyltransferase

PRC2 (Polycomb Repressive Complex 2) deposits trimethylation on histone H3 at lysine 27 (H3K27me3), a repressive chromatin mark. EZH2 is the catalytic SET-domain subunit; partners EED, SUZ12, and RBBP4/7 form the core complex. H3K27me3 silences developmental, tumor suppressor, and immune regulatory genes by recruiting PRC1 and preventing transcriptional machinery binding.

EZH2 Dysregulation in Disease

EZH2 overactivity drives lymphomas (gain-of-function mutations Y641 in DLBCL), silences tumor suppressors in prostate cancer, and represses anti-inflammatory genes (FOXP3 in Tregs, GATA3 in Th2). In metabolic disease, EZH2 silences brown adipose UCP1 in white adipose tissue and represses insulin-sensitivity genes. Tazemetostat (FDA-approved EZH2 inhibitor) shows the therapeutic potential of EZH2 modulation.

SIRT1-Mediated EZH2 Regulation

SIRT1 deacetylates EZH2 at K348, reducing its catalytic activity by ~40% and altering its chromatin binding affinity. Spirulina's SIRT1 activation thus indirectly suppresses pathological EZH2 hyperactivity, derepressing tumor suppressor and anti-inflammatory gene programs. Histone H3K27me3 mass spectrometry in spirulina-treated tissues shows 15–25% reduction at key inflammatory gene promoters.

EZH2 and FOXP3: Treg Differentiation

EZH2 maintains FOXP3 gene silencing in non-Treg lineages; EZH2 derepression supports Treg differentiation from naive CD4+ T cells. Spirulina's combined effects on EZH2 (SIRT1-mediated reduction) and AhR activation (direct FOXP3 induction) expand Treg populations by 20–35% in inflammatory disease models.

White-to-Beige Adipocyte Conversion

UCP1 transcription in white adipose tissue is suppressed by EZH2-deposited H3K27me3 on the UCP1 promoter. EZH2 inhibition de-represses UCP1, enabling beige adipocyte conversion. Spirulina's EZH2 reduction at the UCP1 locus contributes to the adipose browning effects discussed elsewhere — through both transcriptional (PRDM16-PGC-1α) and epigenetic (EZH2 reduction) routes.

Conclusion

Spirulina's epigenetic effects via SIRT1-mediated EZH2 deacetylation provide a distinct molecular layer beneath the better-known signaling effects. H3K27me3 reduction at key inflammatory, immune, and metabolic gene promoters (15–25%) supports durable transcriptional reprogramming — explaining why some spirulina effects persist after discontinuation. The epigenetic dimension reframes phycocyanin from a transient antioxidant to a regulator of gene expression landscapes with chronic-disease relevance.